<DOCUMENT>
<TYPE>EX-10.39
<SEQUENCE>4
<FILENAME>a2105469zex-10_39.htm
<DESCRIPTION>EX-10.39
<TEXT>
<HTML>
<HEAD>

</HEAD>
<BODY BGCOLOR="#FFFFFF" LINK=BLUE  VLINK=PURPLE>
<BR>
<FONT SIZE=3 ><A HREF="#03MOC1141_3">QuickLinks</A></FONT>
<font size=3> -- Click here to rapidly navigate through this document</font>
<!-- TOC_END -->
<P ALIGN="RIGHT"><FONT SIZE=2><A
NAME="ko1142_exhibit_10.39"> </A>
<A NAME="toc_ko1142_1"> </A>
<BR></FONT><FONT SIZE=2><B>Exhibit 10.39    <BR>  </B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B>AMENDMENT NO. 1 TO RECEIVABLES PURCHASE AGREEMENT  </B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B><I>THIS AMENDMENT NO. 1 TO RECEIVABLES PURCHASE AGREEMENT</I></B></FONT><FONT SIZE=2> (this
"</FONT><FONT SIZE=2><B><I>Amendment</I></B></FONT><FONT SIZE=2>")</FONT><FONT SIZE=2><B><I>,</I></B></FONT><FONT SIZE=2> dated as of February&nbsp;1, 2001, is entered into by and among: </FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;Edwards
Lifesciences Financing LLC, a Delaware limited liability company (</FONT><FONT SIZE=2><B><I>"Seller"</I></B></FONT><FONT SIZE=2>), </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;Edwards
Lifesciences LLC, a Delaware limited liability company (</FONT><FONT SIZE=2><B><I>"Edwards"</I></B></FONT><FONT SIZE=2>), as initial Servicer, </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;Blue
Ridge Asset Funding Corporation, a Delaware corporation (</FONT><FONT SIZE=2><B><I>"Blue Ridge"</I></B></FONT><FONT SIZE=2>), and </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;Wachovia
Bank, N.A., as agent for Blue Ridge and its assigns under the Transaction Documents and under the Liquidity Agreement (together with its successors and assigns
in such capacity, the </FONT><FONT SIZE=2><B><I>"Agent"</I></B></FONT><FONT SIZE=2>). </FONT></P>

<P><FONT SIZE=2><B><I>Unless defined elsewhere herein, capitalized terms used in this Amendment shall have the meanings assigned to such terms in Exhibit&nbsp;I to the RPA (as defined
below).</I></B></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="ko1142_preliminary_statements"> </A>
<A NAME="toc_ko1142_2"> </A>
<BR></FONT><FONT SIZE=2><B><I>PRELIMINARY STATEMENTS    <BR>  </I></B></FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller, Edwards, Blue Ridge and the Agent are parties to that certain Receivables Purchase Agreement, dated as of December&nbsp;21, 2000 (the "RPA"). </FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
parties desire to amend the RPA in accordance with the terms hereof. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="ko1142_article_i._amendments"> </A>
<A NAME="toc_ko1142_3"> </A>
<BR></FONT><FONT SIZE=2><B>ARTICLE I.    <BR>    <BR>    AMENDMENTS    <BR>  </B></FONT></P>

<P><FONT SIZE=2>Section&nbsp;1.1</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Amendment to Section&nbsp;1.1(a) of the RPA.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.1(a)
of the RPA is hereby amended and restated in its entirety as follows: </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;Upon
the terms and subject to the conditions of this Agreement (including, without limitation, Article&nbsp;VI), from time to time prior to the Facility Termination
Date, Seller will sell to Blue Ridge, and Blue Ridge will purchase from Seller, undivided ownership interests in the Receivables and the associated Related Security and Collections; </FONT> <FONT SIZE=2><B><I>provided that</I></B></FONT><FONT SIZE=2>
no Purchase shall be made by Blue Ridge if, after giving effect thereto, either (i)&nbsp;the Aggregate Invested Amount would exceed the
Purchase Limit, or (ii)&nbsp;the aggregate of the Receivable Interests would exceed 100%. It is the intent of Blue Ridge to fund the Purchases by the issuance of Commercial Paper. If for any reason
Blue Ridge is unable, or determines that it is undesirable, to issue Commercial Paper to fund or maintain its investment in the Receivable Interests, or is unable for any reason to repay such
Commercial Paper upon the maturity thereof, Blue Ridge will avail itself of a Liquidity Funding to the extent available. If Blue Ridge funds or refinances its investment in a Receivable Interest
through a Liquidity Fundings, in lieu of paying CP Costs on the Invested Amount pursuant to Article&nbsp;III hereof, Seller will pay Yield thereon at the Alternate Base Rate or the LIBO Rate,
selected in accordance with Article&nbsp;IV hereof. Nothing herein shall be deemed to constitute a commitment of Blue Ridge to issue Commercial Paper. </FONT></P>

</UL>

<P><FONT SIZE=2>Section&nbsp;1.2</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;Amendment to Section&nbsp;1.2 of the RPA.</I></FONT><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;1.2
of the RPA is hereby amended and restated in its entirety as follows: </FONT></P>

<UL>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Seller
shall provide the Agent with at least two (2)&nbsp;Business Days' prior written notice in a form set forth as Exhibit&nbsp;II hereto of each Incremental Purchase (each, a </FONT> <FONT SIZE=2><B><I>"Purchase Notice"</I></B></FONT><FONT SIZE=2>). Each
Purchase Notice shall be subject to Section&nbsp;6.2 hereof and, except as set forth below, shall be irrevocable and shall
specify the requested Purchase Price (which shall not be less than $1,000,000 or a larger integral multiple of $100,000) and the Purchase Date (which, in the case of any Incremental Purchase after the
initial Purchase hereunder, shall only be on a Settlement Date). </FONT></P>

</UL>
<HR NOSHADE>
<!-- ZEQ.=1,SEQ=1,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="3",CHK=493733,FOLIO='blank',FILE='DISK006:[03MOC2.03MOC1142]KO1142A.;6',USER='TCHAN',CD='14-MAR-2003;04:54' -->
<A NAME="page_ko1142_1_2"> </A>
<UL>

<P><FONT SIZE=2>
Following receipt of a Purchase Notice, the Agent will determine whether Blue Ridge will fund the requested Incremental Purchase through the issuance of Commercial Paper or through a Liquidity
Funding, and Blue Ridge will fund such Incremental Purchase in accordance with the Agent's determination. On each Purchase Date, upon satisfaction of the applicable conditions precedent set forth in
Article&nbsp;VI, Blue Ridge shall deposit to the Facility Account, in immediately available funds, no later than 2:00&nbsp;p.m. (New York time), an amount equal to the requested Purchase Price. </FONT></P>

</UL>

<P><FONT SIZE=2>Section&nbsp;1.3</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;</I></FONT><FONT SIZE=2><U>Amendment to Section&nbsp;2.5 of the RPA</U>.&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section&nbsp;2.5
of the RPA is hereby deleted in its entirety. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><A
NAME="ko1142_article_ii._miscellaneous"> </A>
<A NAME="toc_ko1142_4"> </A>
<BR></FONT><FONT SIZE=2><B>ARTICLE II.    <BR>    <BR>    MISCELLANEOUS    <BR>  </B></FONT></P>

<P><FONT SIZE=2>Section&nbsp;2.1</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;</I></FONT><FONT SIZE=2><U>Full Force and Effect</U>.&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Amendment amends the terms and conditions of the RPA and, except as amended hereby, all such terms and conditions in the RPA shall remain unmodified and in full force and effect and
are incorporated by reference herein to the same extent as though fully set forth herein. </FONT></P>

<P><FONT SIZE=2>Section&nbsp;2.2</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;</I></FONT><FONT SIZE=2><U>CHOICE OF LAW</U>.&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>


<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;THIS
AMENDMENT SHALL BE GOVERNED AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, without regard to the principles of conflicts of laws thereof OTHER THAN SECTION
5-1401 OF THE GENERAL OBLIGATIONS LAW. </FONT></P>

<P><FONT SIZE=2>Section&nbsp;2.3</FONT><FONT
SIZE=2><I>&nbsp;&nbsp;&nbsp;&nbsp;</I></FONT><FONT SIZE=2><U>Counterparts</U>.&nbsp;&nbsp;&nbsp;&nbsp;</FONT></P>

<P><FONT SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This
Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original
and all of which when taken together shall constitute one and the same Amendment. </FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2><I>&lt;signature pages follow&gt;</I></FONT></P>

<P ALIGN="CENTER"><FONT SIZE=2>2</FONT></P>

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=2,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="3",CHK=938909,FOLIO='2',FILE='DISK006:[03MOC2.03MOC1142]KO1142A.;6',USER='TCHAN',CD='14-MAR-2003;04:54' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->

<P><FONT SIZE=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><FONT SIZE=2><B><I>IN WITNESS WHEREOF,</I></B></FONT><FONT SIZE=2> the parties hereto have caused this Amendment No.&nbsp;1 to Receivables Purchase Agreement to be executed and
delivered by their duly authorized officers or attorneys-in-fact as of the date hereof. </FONT></P>

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="76%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="BOTTOM">
<TD COLSPAN=2 VALIGN="TOP"><FONT SIZE=2>EDWARDS LIFESCIENCES FINANCING LLC<BR></FONT>
</TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="4%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="96%"><BR><HR NOSHADE><FONT SIZE=2> Name:<BR>
Title:</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="5%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="18%" ALIGN="CENTER"><FONT SIZE=2><BR>
Address:</FONT></TD>
<TD WIDTH="76%"><FONT SIZE=2><BR>
One Edwards Way<BR>
M/S 27X<BR>
Irvine, California 92614<BR>
Attention: Dan Gallagher<BR>
Telephone: (949)&nbsp;250-2250<BR>
Facsimile: (949)&nbsp;250-2248</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="76%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=2><FONT SIZE=2><BR>
EDWARDS LIFESCIENCES LLC</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="4%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="96%"><BR><HR NOSHADE><FONT SIZE=2> Name:<BR>
Title:</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="5%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="18%" ALIGN="CENTER"><FONT SIZE=2><BR>
Address:</FONT></TD>
<TD WIDTH="76%"><FONT SIZE=2><BR>
One Edwards Way<BR>
M/S 27X<BR>
Irvine, California 92614<BR>
Attention: Dan Gallagher<BR>
Telephone: (949)&nbsp;250-2250<BR>
Facsimile: (949)&nbsp;250-2248</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER"><FONT SIZE=2>[Signature
Page] </FONT></P>

<HR NOSHADE>
<!-- ZEQ.=1,SEQ=3,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="3",CHK=771227,FOLIO='blank',FILE='DISK006:[03MOC2.03MOC1142]KP1142A.;4',USER='JBELANG',CD='12-MAR-2003;23:16' -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="76%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=2><FONT SIZE=2>BLUE RIDGE ASSET FUNDING CORPORATION</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD COLSPAN=2><BR><FONT SIZE=2><I>BY: WACHOVIA BANK, N.A., ITS ATTORNEY-IN-FACT</I></FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="4%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="96%"><BR><HR NOSHADE><FONT SIZE=2> Name:<BR>
Title:</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="5%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="18%" ALIGN="CENTER"><FONT SIZE=2><BR>
Address:</FONT></TD>
<TD WIDTH="76%"><FONT SIZE=2><BR>
Blue Ridge Asset Funding Corporation<BR>
100 North Main Street<BR>
Winston&#151;Salem, North Carolina 27150<BR>
Attention: John Dillon<BR>
Telephone: (336)&nbsp;732-2690<BR>
Facsimile: (336)&nbsp;732-5021</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="5%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="18%" ALIGN="CENTER"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="76%"><FONT SIZE=2><BR>
with a copy to:</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="5%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="18%" ALIGN="CENTER"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="76%"><FONT SIZE=2><BR>
Blue Ridge Asset Funding Corporation<BR>
c/o AMACAR Group, LLC<BR>
6525 Morrison Blvd., Suite 318<BR>
Charlotte, North Carolina 28211<BR>
Attention: Douglas K. Johnson<BR>
Telephone: (704)&nbsp;365-0569<BR>
Facsimile: (704)&nbsp;365-1362</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="76%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD COLSPAN=2><BR><FONT SIZE=2>WACHOVIA BANK, N.A.,</FONT><FONT SIZE=2> as a Liquidity Bank and as Agent</FONT></TD>
</TR>
<TR VALIGN="TOP">
<TD WIDTH="4%"><FONT SIZE=2><BR>
By:</FONT></TD>
<TD WIDTH="96%"><BR><HR NOSHADE><FONT SIZE=2> Name:<BR>
Title:</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<!-- User-specified TAGGED TABLE -->
<TABLE WIDTH="100%" BORDER=0 CELLSPACING=0 CELLPADDING=0>
<TR VALIGN="TOP">
<TD WIDTH="5%"><FONT SIZE=2><BR>
&nbsp;</FONT></TD>
<TD WIDTH="18%" ALIGN="CENTER"><FONT SIZE=2><BR>
Address:</FONT></TD>
<TD WIDTH="76%"><FONT SIZE=2><BR>
Wachovia Bank, NA<BR>
191 Peachtree Street, 26<SUP>th</SUP> Floor<BR>
GA-403<BR>
Atlanta, Georgia 30303<BR>
Attention: Elizabeth Wagner<BR>
Telephone: (404)&nbsp;332-1398<BR>
Facsimile: (404)&nbsp;332-5152</FONT></TD>
</TR>
</TABLE>
<!-- end of user-specified TAGGED TABLE -->

<P ALIGN="CENTER"><FONT SIZE=2>[Signature
Page] </FONT></P>

<HR NOSHADE>
<!-- ZEQ.=2,SEQ=4,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="3",CHK=942969,FOLIO='blank',FILE='DISK006:[03MOC2.03MOC1142]KP1142A.;4',USER='JBELANG',CD='12-MAR-2003;23:16' -->
<!-- THIS IS THE END OF A COMPOSITION COMPONENT -->
<BR>
<P><br><A NAME="03MOC1141_3">QuickLinks</A><br></P><!-- TOC_BEGIN -->
<UL>
<FONT SIZE=2><A HREF="#toc_ko1142_1">Exhibit 10.39</A></FONT><BR>
</UL>
<FONT SIZE=2><A HREF="#toc_ko1142_2">PRELIMINARY STATEMENTS</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ko1142_3">ARTICLE I. AMENDMENTS</A></FONT><BR>
<FONT SIZE=2><A HREF="#toc_ko1142_4">ARTICLE II. MISCELLANEOUS</A></FONT><BR>
<!-- SEQ=,FILE='QUICKLINK',USER=JHILL,SEQ=,EFW="2105469",CP="EDWARDS LIFESCIENCES CORPORATION",DN="3" -->
<!-- TOCEXISTFLAG -->
</BODY>
</HTML>

</TEXT>
</DOCUMENT>
